India, March 25 -- An American jury has found Indian-origin judge KP George guilty on two counts of money laundering, according to media reports. He now faces a potential prison sentence of between t... Read More
Dhaka, March 25 -- The US and Israeli strikes on Iran last month plunged the Middle East into crisis, disrupted global shipping routes and spawned a series of headaches for Umar Ali Hyder Ali's used-c... Read More
India, March 25 -- Iran has rejected a proposal from the United States to end the ongoing conflict, declaring that any ceasefire will happen only on its own terms and conditions, media reports said. ... Read More
Dhaka, March 25 -- Pressure at filling stations across Bangladesh remains high despite the withdrawal of rationing, with shortages, closures, and limited sales reported in different areas. To bridge ... Read More
Jakarta, March 25 -- Indonesia could save up to Rp40 trillion (US$2.2 billion) annually by trimming operating days for its Free Nutritious Meals (MBG) program, Finance Minister Purbaya Yudhi Sadewa sa... Read More
Singapore, March 25 -- The Health Sciences Authority received information related to the study titled 'ROSETTA CRC-203: A Blinded, Randomized Phase 2/3 Study of Pumitamig in Combination with Chemother... Read More
Singapore, March 25 -- The Health Sciences Authority received information related to the study titled 'A Phase 3, Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study to Evaluate the Safe... Read More
Singapore, March 25 -- The Health Sciences Authority received information related to the study titled 'A Phase III, Randomized, Open-Label, Multicenter, Global Study of Puxitatug Samrotecan (AZD8205) ... Read More
Singapore, March 25 -- The Health Sciences Authority received information related to the study titled 'DAREON®-Lung 1: A Phase III multi-center, open-label, randomised trial of intravenous obrixtamig ... Read More
Singapore, March 25 -- The Health Sciences Authority received information related to the study titled 'DAREON®-Lung 1: A Phase III multi-center, open-label, randomised trial of intravenous obrixtamig ... Read More